Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,156,065
  • Shares Outstanding, K 30,327
  • Annual Sales, $ 992,580 K
  • Annual Income, $ 507,360 K
  • 60-Month Beta 1.55
  • Price/Sales 1.18
  • Price/Cash Flow 2.20
  • Price/Book 0.90
Trade FLGT with:

Options Overview Details

View History
  • Implied Volatility 60.09% ( +0.52%)
  • Historical Volatility 30.69%
  • IV Percentile 17%
  • IV Rank 19.13%
  • IV High 101.13% on 11/08/21
  • IV Low 50.38% on 09/20/22
  • Put/Call Vol Ratio 0.31
  • Today's Volume 152
  • Volume Avg (30-Day) 422
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 14,445
  • Open Int (30-Day) 14,377

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year 3.93
  • Growth Rate Est. (year over year) -100.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.33 +1.19%
on 09/23/22
45.15 -16.32%
on 09/12/22
-3.82 (-9.18%)
since 09/02/22
3-Month
37.33 +1.19%
on 09/23/22
65.17 -42.03%
on 08/04/22
-17.74 (-31.95%)
since 07/01/22
52-Week
37.33 +1.19%
on 09/23/22
109.55 -65.51%
on 12/20/21
-46.55 (-55.20%)
since 10/01/21

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - FLGT

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT)...

FLGT : 37.78 (-0.89%)
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fulgent Investors of a Lead Plaintiff Deadline of November 21, 2022

/PRNewswire/ -- Attention Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit...

FLGT : 37.78 (-0.89%)
FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT

/PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have...

FLGT : 37.78 (-0.89%)
FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc....

FLGT : 37.78 (-0.89%)
Fulgent Genetics, Inc. Class Action Lawsuit: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in Class Action Against Fulgent Genetics, Inc. (FLGT)

The Class : Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Fulgent Genetics,...

FLGT : 37.78 (-0.89%)
Investor Alert: Fulgent Genetics, Inc. (FLGT) - Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Announces Class Action and Encourages Shareholders to Contact the Firm and Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT)...

FLGT : 37.78 (-0.89%)
FLGT LAWSUIT ALERT: Levi & Korsinsky Notifies Fulgent Genetics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities...

FLGT : 37.78 (-0.89%)
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the...

FLGT : 37.78 (-0.89%)
FLGT Investors Have Opportunity to Lead Fulgent Genetics, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action...

FLGT : 37.78 (-0.89%)
FULGENT GENETICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Fulgent Genetics,

/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District...

FLGT : 37.78 (-0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process...

See More

Key Turning Points

3rd Resistance Point 39.77
2nd Resistance Point 39.31
1st Resistance Point 38.54
Last Price 37.78
1st Support Level 37.32
2nd Support Level 36.86
3rd Support Level 36.09

See More

52-Week High 109.55
Fibonacci 61.8% 81.96
Fibonacci 50% 73.44
Fibonacci 38.2% 64.92
Last Price 37.78
52-Week Low 37.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar